![Michael Sweeney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Sweeney
Directeur Technique/Scientifique/R&D chez
RESVERLOGIX CORP.
Fortune : 11 338 $ au 31/05/2026
Profil
Dr. Michael T.
Sweeney, MD, is a Senior Vice President-Clinical Development at Resverlogix Corp.
Dr. Sweeney was previously employed as a Chief Medical Officer, VP-Research & Development by Depomed, Inc., a Vice President-Medical Affairs by CV Therapeutics, Inc., a Senior Director-Urology Global Medial Group Leader by Pfizer Inc., and a Senior Clinical Pharmacologist by Zeneca Group Plc.
He received his doctorate degree from The University of Liverpool.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RESVERLOGIX CORP. 0,05 % | 02/04/2025 | 155 312 ( 0,05 % ) | 11 338 $ | 31/05/2026 |
Postes actifs de Michael Sweeney
| Sociétés | Poste | Début |
|---|---|---|
| RESVERLOGIX CORP. | Directeur Technique/Scientifique/R&D | 03/11/2014 |
Anciens postes connus de Michael Sweeney
| Sociétés | Poste | Fin |
|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/2014 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Directeur Technique/Scientifique/R&D | 01/09/2007 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2003 |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Corporate Officer/Principal | - |
Formation de Michael Sweeney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Resverlogix Corp.
 Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Health Technology |
